Andrews, G. (2001) Placebo response in depression: bane of research, boon to therapy. British Journal of Psychiatry, 178, 192–194.
Antonuccio, D. O., Danton, W. V., DeNelsky, G. Y., et al (1999) Raising questions about antidepressants. Psychotherapy and Psychosomatics, 68, 3–14.
Barsky, A. J. & Borus, J. F. (1995) Somatization and medicalization in the era of managed care. JAMA, 274, 1931–1934.
Blashki, T. G., Mowbray, R. & Davies, B. (1971) Controlled trial of amitriptyline in general practice. BMJ, i, 133–138.
Bollini, P., Pampallona, S., Tibaldi, G., et al (1999) Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. British Journal of Psychiatry, 174, 297–303.
Even, C., Siobud-Dorocant, E. & Dardennes, R. M. (2000) Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable. British Journal of Psychiatry, 177, 47–51.
Freemantle, N., Anderson, I. M. & Young, P. (2000) Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. British Journal of Psychiatry, 177, 292–302.
Greenberg, R. P., Bornstein, R. F., Greenberg, M. D., et al (1992) A meta-analysis of antidepressant outcome under ‘blinder’ conditions. Journal of Consulting and Clinical Psychology, 60, 664–669.
Greenberg, R. P., Bornstein, R. F., Zborowski, M. J., et al (1994) A meta-analysis of fluoxetine outcome in the treatment of depression. Journal of Nervous and Mental Disease, 182, 547–551.
Greenberg, R. P. & Fisher, S. (1997) Mood mending medicines: probing drug, psychotherapy and placebo solutions. In From Placebo to Panacea: Putting Psychiatric Drugs to the Test (eds Greenberg, R. P. & Fisher, S.), pp. 115–172. New York: John Wiley & Sons.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Imlah, N. W. (1985) An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression. british Journal of Psychiatry, 146, 515–519.
McNair, D. M. (1974) Self-evaluations of antidepressants. Psychopharmacologia, 37, 281–302.
Medical Research Council (1965) Clinical trial of the treatment of depressive illness. BMJ, i, 881–886.
Moncrieff, J., Wessely, S. & Hardy, R. (1998) Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 172, 227–231.
Moncrieff, J. (2001) Are antidepressants over-rated? A review of methodological problems in antidepressant trials. Journal of Nervous and Mental Disease, 189, 288–295.
Montgomery, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Morris, J. B. & Beck, A. T. (1974) The efficacy of antidepressant drugs. A review of research (1958 to 1972). Archives of General Psychiatry, 30, 667–674.
Murray, E. J. (1989) Measurement issues in the evaluation of psychopharmacological therapy. In The Limits of Biological Treatments for Psychological Distress (eds Fisher, S. & Greenberg, R. P.), pp. 39–68. Hillsdale, NJ: Lawrence Erlbaun.
Philipp, M., Kohnen, R. & Hiller, K. P. (1999) Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ, 319, 1534–1538.
Quitkin, F. M., Rabkin, J. G., Gerald, J., et al (2000) Validity of clinical trials of antidepressants. American Journal of Psychiatry, 157, 327–337.
Raskin, A., Schulterbrandt, J. G., Reatig, N., et al (1970) Differential response to chlorpromazine, imipramine and placebo. Archives of General Psychiatry, 23, 164–173.
Rickels, K., Gordon, P. E., Gansman, D. H., et al (1970) Pemoline and methylphenidate in mildly depressed outpatients. Clinical Pharmacology and Therapeutics, II, 698–710.
Robertson, M. M. & Trimble, M. R. (1982) Major tranquillisers used as antidepressants. A review. Journal of Affective Disorders, 4, 173–193.
Robinson, D. S., Rickels, K., Feighner, J., et al (1990) Clinical effects of 5-HTIA partial agonists in depression: a composite analysis of buspirone in the treatment of depression. Journal of Clinical Psychopharmacology, 10 (suppl. 3), 67S–76S.
Rogers, S. C. & Clay, P. M. (1975) A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illness. British Journal of Psychiatry, 127, 599–603.
Thomson, R. (1982) Side effects and placebo amplification. British Journal of Psychiatry, 140, 64–68.